Predictive Pneumonia Care: Harnessing Machine Learning to Foresee Early Ventilator Need

Pneumonia remains a leading critical illness in the ICU, with many patients quickly deteriorating into respiratory failure that requires invasive mechanical ventilation (IMV). Because traditional clinical decisions often... read more

Automated Airway Care: The MICROINHALO Trial on Cuff Pressure and VAP Prevention

The MICROINHALO trial, an international cluster-randomized study across 10 ICUs, investigated whether automated airway management could reduce bacterial tracheal colonization in 250 critically ill intubated patients. The... read more

Parsing Pneumonia: Dual Definitions of Severe CABP Reveal Overlapping Risks and High Mortality

This study analyzed 67,439 patients diagnosed with severe community-acquired bacterial pneumonia (sCABP)—representing nearly a quarter of all CAPB admissions—to compare two major clinical definitions: ICU-sCABP (51.2%... read more

The POCUS Textbook: Learn Point-of-Care Ultrasound of the Blood Vessels, Heart, & Lungs

Bring your physical exam into the modern era by learning point-of-care ultrasound (POCUS). Learn cardiopulmonary POCUS with step-by-step instructions from Dr. Istrail. Over 100 crystal-clear figures beautifully designed... read more

The POCUS Textbook: Learn Point-of-Care Ultrasound of the Blood Vessels, Heart, & Lungs

The Great Escape: How ECMO Weaning Shifts Antibiotic Levels

This case study explores the complex pharmacological landscape of treating a 47-year-old patient with severe renal impairment and pneumonia using ceftazidime–avibactam (CAZ-AVI) while on VA-ECMO support. Researchers... read more

Extracorporeal Life Support for Adults

This book presents a concise, evidence-based review of extracorporeal life support (ECLS) for adult diseases. It describes the use of ECLS with patients who are experiencing severe hypoxemic respiratory failure (ARDS and... read more

Extracorporeal Life Support for Adults

Superbugs Are Winning – Time to Fight Back with the Four-Pillar Plan

The relentless global surge in multidrug-resistant (MDR) infections, vividly illustrated by high rates of carbapenem-resistant Acinetobacter in Western Romania and echoed worldwide, is outpacing outdated diagnostic and treatment... read more

Steroids Save Lives in Severe Pneumonia and ARDS – Without Spiking Superbug Risk

A rigorous new systematic review and meta-analysis of 20 high-quality trials (3,459 patients) confirms that low-dose, short-course systemic corticosteroids significantly reduce short-term mortality in both severe pneumonia... read more

Lungs Hit Hardest: Respiratory Sepsis Survivors Face Sharply Higher Death Rates and Cognitive Decline Years Later

In a large cohort study of 12,854 ICU survivors in Germany, patients who survived respiratory sepsis (RS) – mostly from bacterial pneumonia – had significantly worse long-term outcomes than those who survived SARS-CoV-2... read more

Assessing Vulnerability: Frailty’s Link to ICU Infections

This study outlines the protocol and statistical analysis plan for a preplanned secondary analysis of the PROSPECT trial (Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial). The goal of this research... read more

Scarred Lungs: Identifying Fibrosis Risk After COVID-19 ARDS

This substudy of the large, multicenter RECOVIDS cohort investigated the predictive factors for developing fibrotic changes (FC) in survivors of COVID-19-related Acute Respiratory Distress Syndrome (ARDS) six months after... read more

NAC Dosing Dilemma: Balancing Better Outcomes with Higher Costs in Pneumonia

This study performed a cost-effectiveness analysis comparing the use of two versus three dosage forms of N-acetylcysteine (NAC) as an adjunctive mucolytic therapy for ICU patients with pneumonia. Study Summary and Key... read more

VAEs are Real: Advanced Modeling Confirms Ventilator Events Drive Worse Outcomes

The study by Nakahashi et al. significantly advances our understanding of Ventilator-Associated Events (VAEs) by using advanced causal modeling. Their findings firmly establish that VAEs are clinically significant events... read more

Lung Ultrasound Speeds Up VAP Diagnosis and Improves ICU Outcomes

This prospective randomized controlled study investigated whether using Lung Ultrasound (LUS) as a primary bedside tool for diagnosing Ventilator-Associated Pneumonia (VAP) could outperform the standard radiological approach... read more

Endotracheal Tube Cuff Pressure Monitoring and VAP Occurrence

This study demonstrated that maintaining endotracheal tube cuff pressure at 30 cm H2O through monitoring every 8 h did not result in a greater incidence of under-inflation (pressures ... read more

Serum MANF vs. Severity and Prognosis in Community-acquired Pneumonia Patients

This evidence demonstrated that serum mesencephalic astrocyte-derived neurotrophic factor (MANF) is positively associated with scoring criteria and poor prognosis in community-acquired pneumonia (CAP) patients. Serum... read more

Tocilizumab vs. IVIG in Patients with Severe COVID-19 Pneumonia

Severe COVID-19 patients who received IVIG in the early phase of the disease did not show better clinical outcomes in terms of mortality, hospitalization time and intensive care unit admission compared to those who received... read more

Holy Water Not so Holy: Potential Source of Elizabethkingia Pneumonia and Bacteremia in an Immunocompromised Host

This case report highlights that E. anophelis may indeed cause significant infection and should not be considered a contaminant especially in immunosuppressed individuals. The organism originates from water sources and may... read more

Ventilator-associated Pneumonia Pathogenesis: Old and New Mechanisms

Ventilator-associated pneumonia (VAP), defined as a lung infection that occurs in patients after 48 hours on mechanical ventilation, is among the most frequently found nosocomial infections in intensive care units around... read more

Clinical Characteristics and Survival Outcomes of Invasive Pulmonary Aspergillosis Patients

Invasive pulmonary aspergillosis (IPA) is a severe infectious disease caused by Aspergillus spp. It is associated with high mortality, particularly in immunocompromised patients, as well as in those with COVID-19 pneumonia... read more

Severe Adenoviral Infections: Disease Progression and Poor Prognostic Markers

Low hemoglobin, high serum ferritin, and high LDH in the second week are markers of disease progression and poor prognostic markers in severe adenoviral infections, emphasizing further research and targeted interventions. The... read more

Increased Sodium Levels Associated with Ceftriaxone Administration

Serum sodium elevation is considered a frequent manifestation in critically ill patients, with significant clinical outcomes and requiring timely management. This case report suggests a possible association between the... read more